Hepatitis C

October 29, 2014October 29, 2014

Patient Population Eligible for Hepatitis C Treatment Limited by High Costs

Hepatitis C, News

Despite the hope generated by more efficacious, safer hepatitis C drugs within the past years, a number of patients with the chronic liver disease may not qualify for access to ... Read more

October 28, 2014October 28, 2014

Methadone, Opioid Therapy for Injection-drug Users Found to Reduce HCV Infection

Hepatitis C, News

A new study on the effect of opioid agonist therapy in HCV infection entitled “Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult ... Read more

October 27, 2014October 27, 2014

Spanish HIV-HCV Patients More Difficult to Treat Than Other Ethnic Groups

Hepatitis C, News

Spanish patients suffering from both HIV and hepatitis C virus (HCV) are more difficult to treat than patients from other ethnic groups, due to their genetics, according to recent research conducted in a ... Read more

October 23, 2014October 23, 2014

New Chronic Hepatitis C, Genotype 1 Infection Drug Approved By FDA

Hepatitis C, News

Approval for a new chronic hepatitis C (HCV) treatment, genotype 1 infection in adults, was recently announced by the U.S. Food and Drug Administration (FDA). The drug — Harvoni® (ledipasvir/sofosbuvir) — is manufactured ... Read more

October 22, 2014October 22, 2014

Enanta Foregoes Co-development Option For Hep C Drug With AbbVie

Hepatitis C, News

Enanta Pharmaceuticals, Inc. has just announced it will forego its co-development option with AbbVie for their next-generation protease inhibitor, ABT-493, indicated for the treatment of hepatitis C. The CDC estimates that ... Read more

October 21, 2014October 22, 2014

Sovaldi Better for Cost Issues in Hep C Treatments for Inmates

Hepatitis C, News

The treatment of inmates remains a hot-button issue that includes a wide range of different considerations, ranging from how well cared-for a prisoner should be to the economics involved in maintaining ... Read more

October 20, 2014October 20, 2014

New Oral Drugs Show Promise as Hepatitis C Cure

Hepatitis C, News

A pair of highly promising drug study results are scheduled to be presented during the 22nd United European Gastroenterology Week (UEG Week 2014), which began in Vienna, Austria on Saturday, October 18. The conference will ... Read more

October 16, 2014October 16, 2014

Antibody Identified as Key to Fighting Hepatitis C

Hepatitis C, News

A study on the discovery of neutralizing antibodies to block the hepatitis C virus entitled, “Broadly neutralizing antibodies abrogate established hepatitis C virus infection” may offer a potential therapeutic approach to ... Read more

October 15, 2014October 15, 2014

New Hepatitis C Cure Shows Promise in Small Trial

Hepatitis C, News

Promising data on hepatitis C virus (HCV) genotype 3 therapy was released by Biotron Ltd, an Australian drug development company, showing that treatment with its lead antiviral drug, BIT225, led to ... Read more

October 13, 2014October 13, 2014

Burmans Specialty Pharmacy Awarded for Making HCV Drugs Accessible

Hepatitis C, News

A five-decade leader in the field of pharmaceutical marketing and distributorship, Burmans Specialty Pharmacy, has announced that it is the first recipient of the “Shaping Healthcare Delivery” award at the recently-concluded ... Read more